These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 8302597

  • 1. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
    Lovec H, Sewing A, Lucibello FC, Müller R, Möröy T.
    Oncogene; 1994 Jan; 9(1):323-6. PubMed ID: 8302597
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB.
    Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
    [Abstract] [Full Text] [Related]

  • 3. Induction of cyclin D1 overexpression by activated ras.
    Filmus J, Robles AI, Shi W, Wong MJ, Colombo LL, Conti CJ.
    Oncogene; 1994 Dec; 9(12):3627-33. PubMed ID: 7970723
    [Abstract] [Full Text] [Related]

  • 4. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
    Yu Q, Ciemerych MA, Sicinski P.
    Oncogene; 2005 Oct 27; 24(47):7114-9. PubMed ID: 16103884
    [Abstract] [Full Text] [Related]

  • 5. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc.
    Haas K, Staller P, Geisen C, Bartek J, Eilers M, Möröy T.
    Oncogene; 1997 Jul 10; 15(2):179-92. PubMed ID: 9244353
    [Abstract] [Full Text] [Related]

  • 6. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
    Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV.
    Nature; 1994 Jun 23; 369(6482):669-71. PubMed ID: 8208295
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
    Nikaido T, Li SF, Shiozawa T, Fujii S.
    Cancer; 1996 Sep 15; 78(6):1248-53. PubMed ID: 8826947
    [Abstract] [Full Text] [Related]

  • 11. Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation.
    Marhin WW, Hei YJ, Chen S, Jiang Z, Gallie BL, Phillips RA, Penn LZ.
    Oncogene; 1996 Jan 04; 12(1):43-52. PubMed ID: 8552398
    [Abstract] [Full Text] [Related]

  • 12. Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes.
    Arber N, Sutter T, Miyake M, Kahn SM, Venkatraj VS, Sobrino A, Warburton D, Holt PR, Weinstein IB.
    Oncogene; 1996 May 02; 12(9):1903-8. PubMed ID: 8649851
    [Abstract] [Full Text] [Related]

  • 13. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC, Yamamoto S, Wanibuchi H, Wada S, Sugimura K, Kishimoto T, Fukushima S.
    Cancer Res; 1997 Nov 01; 57(21):4765-76. PubMed ID: 9354438
    [Abstract] [Full Text] [Related]

  • 14. A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer.
    Guerra E, Trerotola M, Dell' Arciprete R, Bonasera V, Palombo B, El-Sewedy T, Ciccimarra T, Crescenzi C, Lorenzini F, Rossi C, Vacca G, Lattanzio R, Piantelli M, Alberti S.
    Cancer Res; 2008 Oct 01; 68(19):8113-21. PubMed ID: 18829570
    [Abstract] [Full Text] [Related]

  • 15. Specific protection against breast cancers by cyclin D1 ablation.
    Yu Q, Geng Y, Sicinski P.
    Nature; 2001 Jun 28; 411(6841):1017-21. PubMed ID: 11429595
    [Abstract] [Full Text] [Related]

  • 16. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
    Karsunky H, Geisen C, Schmidt T, Haas K, Zevnik B, Gau E, Möröy T.
    Oncogene; 1999 Dec 16; 18(54):7816-24. PubMed ID: 10618723
    [Abstract] [Full Text] [Related]

  • 17. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation.
    Uchimaru K, Endo K, Fujinuma H, Zukerberg L, Arnold A, Motokura T.
    Jpn J Cancer Res; 1996 May 16; 87(5):459-65. PubMed ID: 8641982
    [Abstract] [Full Text] [Related]

  • 18. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.
    Sinibaldi D, Wharton W, Turkson J, Bowman T, Pledger WJ, Jove R.
    Oncogene; 2000 Nov 16; 19(48):5419-27. PubMed ID: 11114718
    [Abstract] [Full Text] [Related]

  • 19. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach.
    Nakagawa H, Wang TC, Zukerberg L, Odze R, Togawa K, May GH, Wilson J, Rustgi AK.
    Oncogene; 1997 Mar 13; 14(10):1185-90. PubMed ID: 9121767
    [Abstract] [Full Text] [Related]

  • 20. Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors.
    Rosenberg CL, Motokura T, Kronenberg HM, Arnold A.
    Oncogene; 1993 Feb 13; 8(2):519-21. PubMed ID: 8426754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.